SCHEMBL24414215

SCHEMBL24414215

CCC(CC)COC(=O)[C@H](C)N[PH](=O)OC[C@@H](OC#N)[C@@H](O)[C@@H](O)c1ccc2c(N)ncnn12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27054784 0.89 RIPK1 (0.30) —
SCHEMBL25012634 0.87 — —
SCHEMBL21283626 0.86 — —
SCHEMBL26210833 0.79 RIPK1 (0.33) —
SCHEMBL25804278 0.78 — —
SCHEMBL25519303 0.77 POLRMT (0.30) —
SCHEMBL25013436 0.76 MEN1 (0.33) —
SCHEMBL23844017 0.76 RIPK1 (0.32) —
SCHEMBL23818667 0.75 — —
SCHEMBL26333107 0.75 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230338409-A1 NUCLEOSIDE DRUGS FOR THE TREATMENT OR PREVENTION OF CORONAVIRUS INFECTION AND THEIR USES MIRACURE BIOTECHNOLOGY LTD (CN) 2023-10-26 — — US disclosed
US-20230279015-A1 COMPOUNDS AND METHODS FOR TREATMENT OF VIRAL INFECTIONS GILEAD SCIENCES, INC. 2023-09-07 — — US disclosed
US-20230279013-A1 COMPOUNDS AND METHODS FOR TREATMENT OF VIRAL INFECTIONS GILEAD SCIENCES, INC. 2023-09-07 — — US disclosed
US-20230279014-A1 COMPOUNDS AND METHODS FOR TREATMENT OF VIRAL INFECTIONS GILEAD SCIENCES, INC. 2023-09-07 — — US disclosed
US-11377456-B2 Crystalline form of Remdesivir APOTEX INC. (CA) 2022-07-05 — — US disclosed
US-20220144866-A1 Crystalline Form of Remdesivir THE BANK OF NOVA SCOTIA (CA) 2022-05-12 — — US disclosed
Send feedback